Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Immunogen Inc
(NQ:
IMGN
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Feb 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Immunogen Inc
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 03, 2023
From
ImmunoGen, Inc.
Via
Business Wire
5 Sizzling Stocks That Are Outperformers in the Market This Year
July 02, 2023
Looking for the top-performing stocks and market outperformers? Discover the hot stocks to buy and maximize your investment potential.
Via
InvestorPlace
MoonLake Immunotherapeutics Makes a Moonshot on Trials
June 28, 2023
Clinical-stage biotech MoonLake Immunotherapeutics AG (NASDAQ: MLTX) shares spiked 70% on positive clinical trial results.
Via
MarketBeat
Exposures
Product Safety
ImmunoGen Stock Continues to Defy Gravity on Phase 2 Trials
June 26, 2023
ImmunoGen Inc. (NASDAQ: IMGN) is a commercial-stage biotechnology company leading in antibody-drug conjugates (ADC). ADCs are like heat-seeking missiles t
Via
MarketBeat
Midcap Biotech Stock ImmunoGen is Shooting Higher Today: Here's Why
June 09, 2023
ImmunoGen Inc (NASDAQ: IMGN) announced updated
Via
Benzinga
The Latest Analyst Ratings for Immunogen
June 06, 2023
Via
Benzinga
Truist Securities Maintains Buy Rating for Immunogen: Here's What You Need To Know
June 06, 2023
Via
Benzinga
Mersana's UpRi Shows Potential in Ovarian Cancer; Analyst Initiates Coverage with Buy Rating
June 15, 2023
Guggenheim Partners has initiated coverage on Mersana Therapeutics Inc (NASDAQ: MRSN) with a Buy rating
Via
Benzinga
Tesla, Adobe, Mission Produce And Other Big Stocks Moving Higher On Friday
June 09, 2023
U.S. stocks traded higher, with the Dow Jones rising around 100 points on Friday. Here are some big stocks recording gains in today’s session. Braze, Inc. (NASDAQ: BRZE) shares climbed 20.4% to $ 40.82...
Via
Benzinga
Stock Market Rally Broadens Out; Apple Unveils Vision Pro, SEC Sues Binance, Coinbase: Weekly Review
June 09, 2023
The Nasdaq held near 52-week highs while small caps ramped up.
Via
Investor's Business Daily
ImmunoGen Presents Updated Findings from CADENZA Trial of Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell Neoplasm at EHA 2023 Congress
June 09, 2023
From
ImmunoGen Inc.
Via
Business Wire
Midcap Biotech Stock ImmunoGen is Shooting Higher Today: Here's Why
June 05, 2023
Via
Benzinga
Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
June 05, 2023
Gainers Sono Group N.V. (NYSE: SEV) shares surged 152.7% to $0.4367. Sono Group applied to Insolvency Court of Munich, Germany, to permit opening of self-administration proceeding.
Via
Benzinga
ImmunoGen, Day One Surge On Cancer Drug Updates, But Arcus Crashes
June 05, 2023
ImmunoGen and Day One gained Monday on their updates at a cancer treatment conference.
Via
Investor's Business Daily
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
June 05, 2023
It's time to start the week off right with a breakdown of the biggest pre-market stock movers worth watching on Monday morning!
Via
InvestorPlace
Day One Biopharmaceuticals, ImmunoGen And Other Big Stocks Moving Higher In Monday's Pre-Market Session
June 05, 2023
U.S. stock futures traded mixed this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
ELAHERE® Demonstrates 35% Reduction in the Risk of Disease Progression or Death Versus Chemotherapy in FRα-Positive Platinum-Resistant Ovarian Cancer
June 04, 2023
From
ImmunoGen Inc.
Via
Business Wire
AI Boom Wanes In June: Nvidia Falls Under $1T As Benzinga Reviews May's Champions
June 01, 2023
Via
Benzinga
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 01, 2023
From
ImmunoGen, Inc.
Via
Business Wire
Promising Developments Announced Ahead of 2023 ASCO Annual Meeting’s Oral Presentations
May 26, 2023
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GILD),(NASDAQ:IMGN),(NASDAQ:DAWN),(NASDAQ:LEGN) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
Product Safety
10 Health Care Stocks With Whale Alerts In Today's Session
May 25, 2023
Via
Benzinga
ImmunoGen Announces Webcast of Presentation and Q&A at Upcoming Jefferies Healthcare Conference
May 24, 2023
From
ImmunoGen, Inc.
Via
Business Wire
Stocks Stumble, Weekly Wins Still In Sight
May 19, 2023
Stocks are lower midday, paring solid gains from the morning. Despite stumbling into the weekend, all three major indexes are heading toward comfy weekly wins.
Via
Talk Markets
3 Biotech Stocks That Are Revolutionizing Healthcare in 2023
May 19, 2023
Here are three of the best biotech stocks to buy; each is on the verge of significant breakthroughs that may send the price higher.
Via
InvestorPlace
MarketBeat Week in Review – 5/8 - 5/12
May 13, 2023
Inflation, bank woes, interest rates, and the debt ceiling led to more of the new normal for equity markets. Here are some of this week's most popular articles
Via
MarketBeat
Topics
Economy
Electric Vehicles
Exposures
Electric Vehicles
Interest Rates
ImmunoGen Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 09, 2023
From
ImmunoGen, Inc.
Via
Business Wire
ImmunoGen Announces Results from the Phase 3 MIRASOL Trial Selected as Late-Breaking Presentation for ASCO 2023 Annual Meeting
May 09, 2023
From
ImmunoGen, Inc.
Via
Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
May 08, 2023
Via
Benzinga
ImmunoGen Nearly Triples on Ovarian Cancer Drug Phase 3 Results
May 08, 2023
Commercial-state biotechnology company ImmunoGen Inc. (NASDAQ: IMGN) shares more than doubled on phase 3 clinical trial results. Its ovarian cancer drug
Via
MarketBeat
ImmunoGen Announces Pricing of Upsized Public Offering of Common Stock
May 04, 2023
From
ImmunoGen Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.